Bayer Donates Hemophilia Treatments in New Partnership
May 23 2019 - 7:32AM
Dow Jones News
By Dieter Holger
Bayer AG (BAYN.XE) said Thursday that it will donate 50 million
units of hemophilia A treatments this year to support people
suffering from the blood-clotting disorder in countries with poor
healthcare.
The German pharmaceutical giant made the pledge as part of a new
five-year partnership with the World Federation of Hemophilia
Humanitarian Aid Program. The partnership will treat up to 5,000
people in more than 60 countries.
Hemophilia, which is a largely inherited bleeding disorder,
affects around 400,000 people globally, with hemophilia A the most
common variant. Some 75% of people with bleeding disorders live in
developing countries without access to adequate treatment,
according to the WFH.
Write to Dieter Holger at dieter.holger@dowjones.com;
@dieterholger
(END) Dow Jones Newswires
May 23, 2019 07:17 ET (11:17 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Historical Stock Chart
From Apr 2023 to Apr 2024
